Skip to content

The ICU is Your Oyster: Critical Care Clinical Pearls

According to the Society for Critical Care Medicine (SCCM), more than 5 million patients are admitted to intensive care units in the United States each year. As many hospital pharmacists will encounter critically ill patients during their careers, it is essential that they be aware of relevant and unique practice recommendations related to patients in intensive care units (ICU). This CE activity provides important pearls of critical care pharmacy while providing re-education to critical care pharmacists on these topics.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Evaluate critically ill patients for appropriate stress ulcer and venous thromboembolism prophylaxis.
  • Analyze the role of dexmedetomidine as a sedating agent in critically ill patients.
  • Compare hypertonic saline and mannitol for lowering of intracranial pressure in patients with cerebral edema.
  • Assess the utility of low molecular weight heparin anti-Xa assays for apixaban and rivaroxaban.


Hannah Ritchie, PharmD, is a PGY2 Pharmacy Resident at Baystate Medical Center in Springfield, Massachusetts. Hannah earned her Doctor of Pharmacy degree in 2020 from the University of Rhode Island, College of Pharmacy. Hannah’s primary interest areas include critical care, emergency medicine, and academia.

Registration Fee: This module is provided free of charge.


Release Date: June 8, 2022
Expiration Date: June 8, 2023
ACPE UAN: 0026-0000-22-131-H01-P | Application
Topic Designator: Disease State Management/Drug Therapy
Contact Hours:
1 (0. 1 CEU)


ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1 contact hour (0.1 CEU).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Hannah Ritchie has no relevant financial relationships with ineligible companies to disclose.

Residency Director, Frank Szczerba, has no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.